ArticleBreast cancer research and treatment2016

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).

Mehra Golshan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.